Literature DB >> 21301390

Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.

Soyeon Kim1, Jean Marie Arduino, Christine C Roberts, Mark Marsico, Kai-Li Liaw, Finn Egil Skjeldestad.   

Abstract

BACKGROUND: Natural history data on human papillomavirus (HPV) incidence and its risk factors have not been reported on from young women in Norway. We report on incidence and predictors of HPV-6, 11, 16, and 18; 6 or 11; 16 or 18; or all 4.
METHODS: A 48-month prospective study enrolled 898 women aged 16 to 24 between 1998 and 2000. HPV DNA polymerase chain reaction testing of genital tract specimens was performed and risk data collected every 6 months and HPV serology and genital Chlamydia trachomatis testing performed every 12 months. Cumulative incidence was estimated using the Kaplan-Meier method and covariates evaluated in Cox models.
RESULTS: Among the women who were HPV DNA- and serology-negative at entry, 48-month cumulative incidences (95% confidence interval) were as follows: HPV-6: 20.0% (17.1-23.4), HPV-11: 2.2% (1.3-3.5), HPV-16: 25.0% (21.7-28.8), HPV-18: 13.6% (11.3-16.4), HPV-6 or -11: 21.5% (18.5-25.0), HPV-16 or -18: 30.4% (26.7-34.5), and HPV-6, -11, -16, or -18: 37.8% (33.6-42.3). Younger age at first intercourse, being single, having no regular partner, reporting new partners, and genital C. trachomatis infection were independent risk factors of incident HPV.
CONCLUSIONS: Proxies measuring new partnerships and genital C. trachomatis infection predicted incident HPV-6, -11, -16, or -18. Incidence of HPV-6, -11, -16, or -18 in young Norwegian women is high, with more than one-third becoming infected over 48 months.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301390     DOI: 10.1097/OLQ.0b013e31820a9324

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis.

Authors:  Giulia Naldini; Chiara Grisci; Manuela Chiavarini; Roberto Fabiani
Journal:  Int J Public Health       Date:  2019-06-08       Impact factor: 3.380

2.  Association of Chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: the HPV in men study.

Authors:  Catharina Johanna Alberts; Maarten F Schim van der Loeff; Mary R Papenfuss; Roberto José Carvalho da Silva; Luisa Lina Villa; Eduardo Lazcano-Ponce; Alan G Nyitray; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2013-06       Impact factor: 2.830

3.  Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.

Authors:  Pippa Oakeshott; Adamma Aghaizu; Fiona Reid; Rebecca Howell-Jones; Phillip E Hay; S Tariq Sadiq; Charles J Lacey; Simon Beddows; Kate Soldan
Journal:  BMJ       Date:  2012-06-22

4.  Prevalence, Potential Predictors, and Genotype-Specific Prevalence of Human Papillomavirus Infection among Sexually Active Students in Japan.

Authors:  Hirohisa Imai; Hiroyuki Nakao; Hisae Shinohara; Mutsuko Watarai; Noriko Matsumoto; Takuya Yamagishi; Masuko Saito; Tadaichi Kitamura
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 5.  Assessing the social and physical determinants of circumpolar population health.

Authors:  David L Driscoll; Bruce Dotterrer; Richard A Brown
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

Review 6.  Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis.

Authors:  Haiyan Zhu; Zhaojun Shen; Hui Luo; Wenwen Zhang; Xueqiong Zhu
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Sexual behavior and infection with cervical human papillomavirus types 16 and 18.

Authors:  Yuwadee Itarat; Chumnan Kietpeerakool; Nampet Jampathong; Bandit Chumworathayi; Pilaiwan Kleebkaow; Apiwat Aue-Aungkul; Wilasinee Nhokaew
Journal:  Int J Womens Health       Date:  2019-08-26

8.  Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.

Authors:  Sveinung Wergeland Sørbye; Silje Fismen; Tore Jarl Gutteberg; Elin Synnøve Mortensen; Finn Egil Skjeldestad
Journal:  BMJ Open       Date:  2016-08-11       Impact factor: 2.692

9.  Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection.

Authors:  Xin Huang; Qun Zhao; Pingting Yang; Ying Li; Hong Yuan; Liuxin Wu; Zhiheng Chen
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.